These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3524801)

  • 1. Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion.
    Persky B; Ostrowski LE; Pagast P; Ahsan A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4129-34. PubMed ID: 3524801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
    Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells.
    Reich R; Thompson EW; Iwamoto Y; Martin GR; Deason JR; Fuller GC; Miskin R
    Cancer Res; 1988 Jun; 48(12):3307-12. PubMed ID: 2836052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of proteases as anticancer drugs.
    Jedinak A; Maliar T
    Neoplasma; 2005; 52(3):185-92. PubMed ID: 15875078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.
    Schultz RM; Silberman S; Persky B; Bajkowski AS; Carmichael DF
    Cancer Res; 1988 Oct; 48(19):5539-45. PubMed ID: 3416307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells.
    Yagel S; Parhar RS; Jeffrey JJ; Lala PK
    J Cell Physiol; 1988 Sep; 136(3):455-62. PubMed ID: 3170642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteases and their inhibitors in human brain tumours: a review.
    Rooprai HK; McCormick D
    Anticancer Res; 1997; 17(6B):4151-62. PubMed ID: 9428349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.
    Rozhin J; Robinson D; Stevens MA; Lah TT; Honn KV; Ryan RE; Sloane BF
    Cancer Res; 1987 Dec; 47(24 Pt 1):6620-8. PubMed ID: 2824039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
    Masson V
    Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro.
    Thorgeirsson UP; Liotta LA; Kalebic T; Margulies IM; Thomas K; Rios-Candelore M; Russo RG
    J Natl Cancer Inst; 1982 Nov; 69(5):1049-54. PubMed ID: 6752521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.
    Cresson DH; Beckman WC; Tidwell RR; Geratz JD; Siegal GP
    Am J Pathol; 1986 Apr; 123(1):46-56. PubMed ID: 3008561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of cathepsins and the plasminogen activator/inhibitor system in colorectal cancer].
    Herszényi L; Farinati F; Plebani M; István G; Sápi Z; Carraro P; De Paoli M; Naccarato R; Tulassay Z
    Orv Hetil; 1999 Aug; 140(33):1833-6. PubMed ID: 10489782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor and host molecules important in the organ preference of metastasis.
    Nicolson GL
    Semin Cancer Biol; 1991 Jun; 2(3):143-54. PubMed ID: 1912524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteases and tumor invasion].
    Burtin P; Durliat M
    Pathol Biol (Paris); 1990 Dec; 38(10):1034-8. PubMed ID: 2290694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [4-acetamidophenyl retinoate (4-APR) inhibits reconstituted basement membrane invasion by tumor cells and its mechanism].
    Shi B; Han R
    Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):196-9. PubMed ID: 10920895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tumor cell invasion assays: human amnion versus reconstituted basement membrane barriers.
    Hendrix MJ; Seftor EA; Seftor RE; Misiorowski RL; Saba PZ; Sundareshan P; Welch DR
    Invasion Metastasis; 1989; 9(5):278-97. PubMed ID: 2767926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
    Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
    Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.